PF-03654746
Chemical compound / From Wikipedia, the free encyclopedia
PF-03654746 is a potent and selective histamine H3 receptor antagonist developed by Pfizer and currently undergoing clinical trials for the treatment of ADHD, Tourette syndrome[1] as well as potential anti-allergy applications.[2][3][4][5]
Quick Facts Identifiers, CAS Number ...
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C18H24F2N2O |
Molar mass | 322.400 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Close